HCA Share Price | HCA Healthcare, Inc. Stock Analysis & Recommendation

Q: How big is HCA Healthcare, Inc.?

Market Cap: As of Jun 18, HCA Healthcare, Inc. has a market capitalization of 89,601.76 million, categorizing it as a Large Cap company.Recent Quarterly Performance: For the latest four quarters, HCA Healthcare, Inc. reported net sales of 71,585.00 million and a net profit of 6,680.00 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of -2,499.00 million and total assets of 59,513.00 million.

Q: What does HCA Healthcare, Inc. do?

Overview:HCA Healthcare, Inc. is a holding company that owns and operates hospitals and related healthcare entities within the hospital industry and is categorized as a large-cap company.Financial Snapshot:- Most recent Net Sales: 18,321 Million (Quarterly Results - Mar 2025)- Most recent Net Profit: 1,825 Million (Quarterly Results - Mar 2025)- Market-cap: USD 89,601.76 Million (Large Cap)Key Metrics:- P/E: 14.00- Dividend Yield: 83.78%- Debt Equity: -12.34- Return on Equity: -189.83%- Price to Book: -25.46Contact Details:- Address: 1 Park Plz, NASHVILLE TN: 37203-6527- Tel: 1 615 3449551- Website: https://hcahealthcare.com/

Q: Is HCA Healthcare, Inc. overvalued or undervalued?

As of 20 July 2021, the valuation grade for HCA Healthcare, Inc. has moved from attractive to risky, indicating a shift in its investment appeal. The company appears to be overvalued, as evidenced by its P/E ratio of 14, which is higher than the peer average of approximately 14.21, and a significantly negative Price to Book Value of -26.28. Additionally, the EV to EBITDA ratio stands at 9.56, which is also above the industry average, suggesting that the company may not be a favorable investment at its current price.In terms of peer comparison, HCA Healthcare's PEG ratio of 1.15 is lower than the peer average of 1.48, indicating that it may be undervalued in terms of growth expectations relative to its price. However, the overall financial metrics point to a concerning valuation. Notably, HCA's stock has returned 33.62% year-to-date, significantly outperforming the S&P 500's 12.22% return, but this strong performance may not be sustainable given the current valuation risks.

Q: Is HCA Healthcare, Inc. technically bullish or bearish?

As of 4 September 2025, the technical trend for HCA Healthcare, Inc. has changed from mildly bullish to bullish. The MACD is bullish on both the weekly and monthly time frames, while the moving averages indicate a bullish stance on the daily chart. The Bollinger Bands show a mildly bullish trend on both weekly and monthly time frames. However, the KST and OBV indicators are mildly bearish on the weekly chart, with the OBV being bullish on the monthly. Dow Theory indicates a bullish trend on the monthly but no trend on the weekly.In terms of performance, HCA Healthcare has outperformed the S&P 500 year-to-date with a return of 33.62% compared to the S&P 500's 12.22%, but it has underperformed over the past year with a return of 0.29% versus 17.14% for the index. Overall, the current technical stance is bullish, supported by strong MACD and moving average indicators.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.12 M

Shareholding (Dec 2025)

FII

16.56%

Held by 489 FIIs

DII

62.59%

Held by 39 DIIs

Promoter

0.01%

How big is HCA Healthcare, Inc.?

22-Jun-2025

As of Jun 18, HCA Healthcare, Inc. has a market capitalization of $89.6 billion, with recent net sales of $71.6 billion and a net profit of $6.7 billion over the last four quarters.

View full answer

What does HCA Healthcare, Inc. do?

22-Jun-2025

HCA Healthcare, Inc. is a large-cap holding company that operates hospitals and related healthcare entities, with recent net sales of $18.32 billion and a net profit of $1.83 billion. Key metrics include a P/E ratio of 14.00 and a market cap of approximately $89.6 billion.

View full answer

Who are in the management team of HCA Healthcare, Inc.?

22-Jun-2025

As of March 2022, the management team of HCA Healthcare, Inc. includes Chairman Thomas Frist, CEO Samuel Hazen, and several independent directors: Meg Crofton, Robert Dennis, Nancy-Ann DeParle, and Charles Holliday. They are responsible for guiding the company's strategic direction and operations.

View full answer

Is HCA Healthcare, Inc. overvalued or undervalued?

20-Sep-2025

As of July 20, 2021, HCA Healthcare, Inc. is considered a risky investment due to its overvaluation indicated by a P/E ratio of 14, a negative Price to Book Value of -26.28, and an EV to EBITDA ratio of 9.56, despite a lower PEG ratio of 1.15 compared to peers and a strong year-to-date stock return of 33.62%.

View full answer

Is HCA Healthcare, Inc. technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, HCA Healthcare, Inc. shows a bullish technical trend with strong MACD and moving averages, having outperformed the S&P 500 year-to-date but underperformed over the past year.

View full answer

Compare HCA Healthcare, Inc. with Similar Stocks

Universal Health Services, Inc.Chemed Corp.Tenet Healthcare Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Risky - Negative Book Value

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 53.06%, its profits have risen by 5.2% ; the PEG ratio of the company is 1.2

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

USD 117,444 Million (Large Cap)

P/E

15.00

Industry P/E

Dividend Yield

84.76%

Debt Equity

-7.48

Return on Equity

-129.12%

Price to Book

-19.49

Revenue and Profits:

Net Sales:

19,513 Million

(Quarterly Results - Dec 2025)

Net Profit:

2,163 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

5.86%

6 Months

23.14%

1 Year

49.59%

2 Years

50.96%

3 Years

97.03%

4 Years

89.46%

5 Years

162.66%

HCA Healthcare, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.97%

EBIT Growth (5y)

10.50%

EBIT to Interest (avg)

5.33

Debt to EBITDA (avg)

2.95

Net Debt to Equity (avg)

-12.34

Sales to Capital Employed (avg)

1.77

Tax Ratio

22.35%

Dividend Payout Ratio

10.17%

Pledged Shares

Institutional Holding

65.02%

ROCE (avg)

27.03%

ROE (avg)

2,133.20%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-19.49

EV to EBIT

13.58

EV to EBITDA

10.49

EV to Capital Employed

4.16

EV to Sales

2.15

PEG Ratio

0.51

Dividend Yield

84.76%

ROCE (Latest)

30.64%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 171 Schemes (20.84%)

Foreign Institutions

Held by 489 Foreign Institutions (16.56%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.84% vs 2.99% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 13.66% vs 0.63% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19,513.00",
          "val2": "19,161.00",
          "chgp": "1.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,089.00",
          "val2": "3,854.00",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "572.00",
          "val2": "561.00",
          "chgp": "1.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,163.00",
          "val2": "1,903.00",
          "chgp": "13.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "162.90%",
          "val2": "154.70%",
          "chgp": "0.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.08% vs 8.67% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 16.90% vs 9.29% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "75,600.00",
          "val2": "70,603.00",
          "chgp": "7.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15,488.00",
          "val2": "13,859.00",
          "chgp": "11.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,248.00",
          "val2": "2,061.00",
          "chgp": "9.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7,782.00",
          "val2": "6,657.00",
          "chgp": "16.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "158.30%",
          "val2": "149.40%",
          "chgp": "0.89%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

19,513.00

19,161.00

1.84%

Operating Profit (PBDIT) excl Other Income

4,089.00

3,854.00

6.10%

Interest

572.00

561.00

1.96%

Exceptional Items

0.00

Consolidate Net Profit

2,163.00

1,903.00

13.66%

Operating Profit Margin (Excl OI)

162.90%

154.70%

0.82%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.84% vs 2.99% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 13.66% vs 0.63% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

75,600.00

70,603.00

7.08%

Operating Profit (PBDIT) excl Other Income

15,488.00

13,859.00

11.75%

Interest

2,248.00

2,061.00

9.07%

Exceptional Items

0.00

Consolidate Net Profit

7,782.00

6,657.00

16.90%

Operating Profit Margin (Excl OI)

158.30%

149.40%

0.89%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 7.08% vs 8.67% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 16.90% vs 9.29% in Dec 2024

All Annual Results

Company CV

About HCA Healthcare, Inc.

HCA Healthcare, Inc.

Hospital

HCA Healthcare, Inc., formerly HCA Holdings, Inc., is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia. As of December 31, 2016, the American Group included 80 hospitals, which were located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. As of December 31, 2016, the Company operated six hospitals in England. The Company owns, manages or operates hospitals, freestanding surgery centers and freestanding emergency care facilities, walk-in clinics, diagnostic and imaging centers, among others.

Company Coordinates

Company Details

1 Park Plz , NASHVILLE TN : 37203-6527

Tel: 1 615 3449551

https://hcahealthcare.com/

Registrar Details